# Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Source: https://onco.cc/trials/nct06177522/  
OnCo record `nct06177522` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of adebrelimab, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Jinling Hospital, China, not yet recruiting.

## Summary

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer is a phase 2, interventional study registered as NCT06177522 by Jinling Hospital, China, with a registry enrolment figure of 30 participants, started 2025-11-30 and due to reach its primary completion in 2027-12-30. Interventions recorded: Adebrelimab; albumin-bound paclitaxel; Gemcitabine. Conditions listed: Pancreatic Cancer; Neoadjuvant Therapy. Primary outcome: R0 removal rate; pCR rate. Pancreatic eligibility wording from the registry: "Patients with resectable pancreatic adenocarcinoma confirmed by histopathology or cytology (CA19-9 \> 150 U/ml);". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06177522
- Phase: 2
- Setting: A Single-arm, Single-center, Exploratory Study of Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
- Sponsor: Jinling Hospital, China
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06177522: https://clinicaltrials.gov/study/NCT06177522

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06177522.json